Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
Blood Advances · 25.07.2023 · 7 (14) · 3658-3665
DOI: 10.1182/bloodadvances.2023009707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Advances, online erschienen am 17.07.2023. Verfasst von Lana Mucalo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Section of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI. Hauptthemen laut MEDLINE: Chronic Pain, Anemia, Sickle Cell. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NINDS NIH HHS.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Chronic pain affects 30% to 40% of individuals with sickle cell disease (SCD) and impairs patient functioning. Clinically meaningful, practical, and valid assessment tools for investigation, evaluation, and management of chronic pain are limited, representing a barrier for advancing SCD care. We sought to determine whether patient-reported outcomes (PROs) show preliminary construct validity in identifying individuals with SCD who were a priori defined as suggestive of having chronic pain based on previously published criteria. All individuals completed the Patient-Reported Outcomes Measurement Information System (PROMIS) domains: pain interference, pain behavior, pain quality (nociceptive, neuropathic), fatigue, sleep disturbance, depression, and anxiety; the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) domains: pain impact and emotional impact; and the painDETECT questionnaire. Thirty-three adults living with SCD were enrolled, and 42.4% had chronic pain. Pain-related PROs scores distinctly differentiated individuals with chronic pain from those without. Individuals with chronic pain had significantly worse pain-related PROs scores: PROMIS pain interference (64.2 vs 54.3), PROMIS pain behavior (63.2 vs 50), and ASCQ-Me pain impact (42.9 vs 53.2). According to published PROMIS clinical cut scores for the pain-related domains, individuals with chronic pain were categorized as having moderate impairment, whereas those without chronic pain had mild or no impairment. Individuals with chronic pain had PRO pain features consistent with neuropathic pain and worse scores in fatigue, depression, sleep disturbance, and emotional impact. Pain-related PROs show preliminary construct validity in differentiating individuals with and without chronic SCD pain and could be used as valuable tools for research and clinical monitoring of chronic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Section of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI.
- Division of Hematology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
- Versiti, Medical Sciences Institute, Milwaukee, WI.
- Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
ORCID-Profile: Lana Mucalo, Joshua J Field, Hamda Khan, Jane S Hankins, Ashima Singh, Amanda M Brandow
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Mucalo, L., Field, J. J., Highland, J., Khan, H., Hankins, J. S., Singh, A., & Brandow, A. M. (2023). Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease. Blood Advances, 7(14), 3658-3665. https://doi.org/10.1182/bloodadvances.2023009707
Vancouver
Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, et al. Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease. Blood Advances. 2023;7(14):3658-3665. doi:10.1182/bloodadvances.2023009707
BibTeX
@article{Mucalo2023,
author = {Mucalo, Lana and Field, Joshua J and Highland, Janelle and Khan, Hamda and Hankins, Jane S and Singh, Ashima and Brandow, Amanda M},
title = {Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease},
journal = {Blood Advances},
year = {2023},
volume = {7},
number = {14},
pages = {3658--3665},
doi = {10.1182/bloodadvances.2023009707}
}
EUVIMED